Bioseeker, Feb 2011
"AnalyticalTool - Melanoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in melanoma R&D and business development. It is at the same time a map
Bioseeker, May 2011
"AnalyticalTool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map
Bioseeker, Feb 2011
"AnalyticalTool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same
Bioseeker, Feb 2011
"AnalyticalTool - Pancreatic Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development
Bioseeker, Feb 2011
"AnalyticalTool - Prostate Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at the same
Bioseeker, March 2011
"AnalyticalTool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development
Bioseeker, Feb 2011
"AnalyticalTool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same time a map
Bioseeker, Sep 2011
"AnalyticalTool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment
Bioseeker, Feb 2011
"AnalyticalTool- Cancer Immunotherapy" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer
Bioseeker, Nov 2011
"AnalyticalTool – Antibodies and Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development
Bioseeker, Nov 2011
"AnalyticalTool- Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in peptide drug development for the treatment of cancer
Bioseeker, Dec 2011
"AnalyticalTool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer
Bioseeker, Jan 2012
"AnalyticalTool - Angiogenesis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment
Bioseeker, July 2011 AnalyticalTool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline Update 2011
Fuji-Keizai USA, Inc., Feb 2010, Pages: 138
This report reviews, analyzes and sizes the stem cell R&D tools & tech product and stem cell therapeutic markets. The study uncovers interesting information about key equipment, consumables
Fuji-Keizai USA, Inc., Jan 2010, Pages: 141
This report reviews, analyzes and sizes the stem cell R&D tools & tech product and stem cell therapeutic markets. The study uncovers interesting information about key equipment, consumables
Bioseeker, June 2006
"AnalyticalTool - The Commercial Success of Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody R
Fuji-Keizai USA, Inc., Jan 2011, Pages: 134
This report reviews, analyzes and sizes the cell-related tool and analytical instrument markets, particularly focusing on the US and EU region, with five-year revenue projections to 2015. It also
Fuji-Keizai USA, Inc., Feb 2011, Pages: 122
This report reviews, analyzes and sizes the cell-related tool and analytical instrument markets, particularly focusing on the US and EU region, with five-year revenue projections to 2015. It also
Bioseeker, May 2007
"AnalyticalTool - Competitive Outlook on Anti-Angiogenesis and Vascular Targeting in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged
